12:00 AM
Nov 23, 2009
 |  BC Week In Review  |  Clinical News  |  Clinical Results

SYN0854: Phase II data

In a double-blind, placebo- and active-controlled, German Phase II trial in 70 subjects, SYN0126 alone and in combination with SYN0854 resulted in mean reductions in TS count at 8...

Read the full 132 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >